This literature review deals with the electrophoretic deposition of bioactive glass coatings on metallic substrates to produce bone implants. Biocompatible metallic materials, such as titanium alloys or stainless steels, are commonly used to replace hard tissue functions because their mechanical properties are appropriate for load-bearing applications. However, metallic materials barely react in the body. They need a bioactive surface coating to trigger beneficial biological and chemical reactions in the physiological environment. Bioactive coatings aim to improve bone bonding, shorten the healing process after implantation, and extend the lifespan of the implant. Bioactive glasses, such as 45S5, 58S, S53P4, 13-93, or 70S30C, are amorphous materials made of a mixture of oxides that are accepted by the human body. They are used as coatings to improve the surface reactivity of metallic bone implants. Their high bioactivity in the physiological environment induces the formation of strong chemical bonding at the interface between the metallic implant and the surrounding bone tissue. Electrophoretic deposition is one of the most effective solutions to deposit uniform bioactive glass coatings at low temperatures. This article begins with a review of the different compositions of bioactive glasses described in the scientific literature for their ability to support hard tissue repair. The second part details the different stages of the bioactivity process occurring at the surface of bioactive glasses immersed in a physiological environment. Then, the mechanisms involved in the electrophoretic deposition of bioactive glass coatings on metallic bone implants are described. The last part of the article details the current developments in the process of improving the properties of bioactive glass coatings by adding biocompatible elements to the glassy structure.